Фуросемид

Active substance: furosemide

раствор для внутривенного и внутримышечного введения, 10 мг/мл, 2 мл (original in Russian, GRLS)

RussiaActive

Marketing holder: ООО "ВИАЛ"

Verified 2026-10-09 · GRLS (Russian state register)

Composition

Analogues by country

Products with the same active substance registered in other countries.

Country	Products
US 214	FUROSCIX INJECTION · FUROSEMIDE 8 mg/mL 71767-100 scPharmaceuticals Inc., a wholly owned subsidiary of MannKind Corporation FUROSCIX INJECTION · FUROSEMIDE 80 mg/mL 71767-111 scPharmaceuticals Inc., a wholly owned subsidiary of MannKind Corporation FUROSEMIDE INJECTION, SOLUTION · FUROSEMIDE 10 mg/mL 36000-282 Baxter Healthcare Corporation FUROSEMIDE TABLET · FUROSEMIDE 20 mg/1 51655-269 Northwind Health Company, LLC FUROSEMIDE TABLET · FUROSEMIDE 40 mg/1 59651-797 Aurobindo Pharma Limited All products in this country (214)
EU 1	Bopediat furosemide EMEA/H/C/006617 Proveca Pharma Limited

Country

Products

US 214

FUROSCIX
INJECTION · FUROSEMIDE 8 mg/mL
71767-100
scPharmaceuticals Inc., a wholly owned subsidiary of MannKind Corporation
FUROSCIX
INJECTION · FUROSEMIDE 80 mg/mL
71767-111
scPharmaceuticals Inc., a wholly owned subsidiary of MannKind Corporation
FUROSEMIDE
INJECTION, SOLUTION · FUROSEMIDE 10 mg/mL
36000-282
Baxter Healthcare Corporation
FUROSEMIDE
TABLET · FUROSEMIDE 20 mg/1
51655-269
Northwind Health Company, LLC
FUROSEMIDE
TABLET · FUROSEMIDE 40 mg/1
59651-797
Aurobindo Pharma Limited

EU 1

Import and control

United Statesprescription only
Source: openFDA NDC · record 01a1208c-272b-7ba3-9ef1-c246c5c61620,01a1208c-273e-7285-a1a4-ffc548f494ee,01a1208c-2777-78ed-b344-9a48408b974b,01a1208c-2938-75b3-ad42-ecaeb3fda8f2,01a1208c-4638-7ab8-a52f-7dcd7fb4f011;count=214 · valid from 2026-10-09 · verified 2026-10-09